APA

Berg S. L., Blaney S. M., Devidas M., Lampkin T. A., Murgo A., Bernstein M., Billett A., Kurtzberg J., Reaman G., Gaynon P., Whitlock J., Krailo M. & Harris M. B. (20050624). Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Berg Stacey L, Blaney Susan M, Devidas Meenakshi, Lampkin Tom A, Murgo Anthony, Bernstein Mark, Billett Amy, Kurtzberg Joanne, Reaman Greg, Gaynon Paul, Whitlock James, Krailo Mark and Harris Michael B. 20050624. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Berg S. L., Blaney S. M., Devidas M., Lampkin T. A., Murgo A., Bernstein M., Billett A., Kurtzberg J., Reaman G., Gaynon P., Whitlock J., Krailo M. and Harris M. B. (20050624). Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Berg Stacey L, Blaney Susan M, Devidas Meenakshi, Lampkin Tom A, Murgo Anthony, Bernstein Mark, Billett Amy, Kurtzberg Joanne, Reaman Greg, Gaynon Paul, Whitlock James, Krailo Mark and Harris Michael B. Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20050624.